Search the library

Plain words work. Use the arrow keys to move, Enter to open, Esc to close.

Menu

We find what is treatable in autism. Then we test it.

Laboratory and clinical research into folate, mitochondria and the immune system. Tested in blinded trials. Explained in plain language for families.

Just diagnosed? Start here

Dr. Richard Frye in a research laboratory, shelves of sample boxes behind him.
Richard E. Frye, MD, PhDChief Scientific Officer and cofounderPediatric neurologist

134 papers since 2006. One mark is one paper. The ring is the first blinded trial of leucovorin, 2018.

Start where you are

What brings you here today?

For parents

For clinicians

For researchers

For supporters

The evidence·Leucovorin01

Leucovorin has now been tested in 5 blinded trials.

Dr. Frye ran the first, in 2018. Independent groups in 4 countries have since largely repeated the result.

Not an “autism pill”

Leucovorin needs the right patient, the right dose and the right formulation. It is a prescription medicine: the decision belongs with your child’s doctor.

Assigned leucovorin, 155Assigned placebo, 138

Fig. 1Every child in the 5 blinded, controlled trials of leucovorin in autism. One mark is one child: 293 in all. A filled mark was assigned leucovorin, a ring was assigned placebo. The bracket shows how long each trial ran.Source: ADTF statement of 1 October 2025, Appendix C.
Read this as

is a prescription form of folate that doctors have used for more than 80 years. In the first trial, children took leucovorin or a placebo for 12 weeks. The trial was : neither families nor doctors knew who was taking which.

Spoken language improved in the children on leucovorin compared with those on placebo. Later trials, each run by a different research group, largely point the same way.

The 2018 trial was randomized, double-blind and placebo-controlled: 23 children were assigned leucovorin and 25 placebo for 12 weeks, with verbal communication as the outcome (Frye et al., Molecular Psychiatry).

Among children positive for folate receptor autoantibodies, the number needed to treat was 1.8. Randomized, blinded, placebo-controlled trials in 4 other countries have since largely replicated the result: 293 children across the 5 trials.

Read the 2018 trial Understand cerebral folate deficiency

The next step needs funding: project 2B, a new folate compound.

Help fund project 2B
Topics02

Ten lines of inquiry, each starting from a parent’s question.

Every topic gathers its plain-language guide, papers, videos and courses in one place. The line under each shows its share of the 134 papers.

Could my child's brain be low in folate?

Cerebral folate deficiency · When folate cannot reach the brain, and the treatment that gets it there.

11papers

Why does my child lose skills when they are sick?

Mitochondrial dysfunction · How cells make energy, and what happens when they cannot keep up.

48papers

Which treatments have been tested properly?

Treatments · Trials and studies of specific treatments, and how strong the evidence is.

46papers

Is there a test for this?

Biomarkers · Blood and cell tests that show which children have a treatable difference.

37papers

What does the immune system have to do with autism?

Immune function · Immune differences, inflammation, and treatments directed at the immune system.

16papers

Are seizures more common in autism?

Seizures and EEG · Seizures, unusual EEG findings, and how they are treated in autism.

8papers

Why are stomach problems so common?

Microbiome and gut · The gut microbiome, stomach and bowel symptoms, and their link to the brain.

8papers

What raises or lowers risk before birth?

Environmental factors · Exposures before and after birth, and how they interact with metabolism.

13papers

Is autism genetic?

Epigenetics and genetics · How genes are switched on and off, and the DNA differences underneath.

14papers

What can a brain scan show?

Neuroimaging · What brain imaging shows about structure, connections and metabolism.

30papers

A paper can sit under more than one topic.

Search all 134 papers

In the news and new in the library

03

Statement·1 October 2025

Our statement on the FDA’s label change for leucovorin

In September 2025 the FDA approved a label change for leucovorin for cerebral folate deficiency. Our response sets out the evidence, trial by trial.

Read the statement

New in the library

All 134 papers

The people

04

Chief Scientific Officer·Cofounder

Richard E. Frye, MD, PhD

A pediatric neurologist, Dr. Frye has studied folate, mitochondria and metabolism in autism for two decades. He led the first double-blind, placebo-controlled trial of leucovorin, which Autism Speaks rated the second most important autism research finding of 2018.

Selected work

Selected papers by Dr. Frye

Leadership

Richard E. Frye, MD, PhD

Chief Scientific Officer · Cofounder

Daniel A. Rossignol, MD, FAAFP

Cofounder

Adrienne C. Scheck, PhD

Research Scientist

Kelly Sirju

Chief Operating Officer

Stella V. Laurella, CPA, MBA

Treasurer

Research team

The research team

Hamsa Raman, MA, CCC-SLP

Clinical Research Coordinator

Sarah Lychy, ND

Investigator

Zoë Hill

Genetic Specialist

Jaclyn Bain, ND, FABNP

Investigator

Christy Coleman, RN, BSN

Pediatric Clinical and Research Specialty Nurse

Cara McCormack-Frye, BS

Pediatric Clinical and Research Associate

Sumedh Seetharam

Research Assistant

Funders

  • The BRAIN Foundation
  • The O’Sullivan Foundation
  • US–Israel Binational Science Foundation
  • The Jonty Foundation
  • XEL Foundation
  • Department of Defense

Research supported in the past by the National Institutes of Health, the Department of Defense and Autism Speaks.

Clinical partners

  • Rossignol Medical CenterA multi-state autism medical clinic directed by ADTF cofounder Dr. Daniel Rossignol.
  • Medical Academy of Pediatric Special Needs (MAPS)Clinician training and a directory of providers.
  • Neuroimmune FoundationExpert panel and education on neuroimmune conditions.

$6.05 million would fund all 16 projects. Choose yours.

Each project has a stated goal. Give where it is needed most, or name the project your gift pays for.

Make a gift

Your gift goes to the research fund, where it is needed most.

Secure checkout on the next stepTax-deductible · 501(c)(3)

Choose a project in the form and its block lights up here.

Fig. 2The whole plan, drawn to scale. One block is one project, as wide as its goal. The blocks show size, not money raised.Source: ADTF project list. Goals as published by the foundation.
Courses and books05

Go deeper, with Dr. Frye as the teacher.

Cover of The Folate Fix by Richard E. Frye, MD, PhD

Book·2025·332 pages

The Folate Fix

Exploring the Role of Folate in Autism and Neurodevelopmental Disorders

The story of folate in autism, told through families’ experiences, with evaluation strategies, treatment practice and answers to the questions clinicians and caregivers ask most.

Books and courses are sold by Metabolic Learning Resource, founded by Dr. Frye, not by the foundation.

Courses·On demand

ADTF Weekly

One email a week. The research, explained.

A short video from Dr. Frye on one new paper, what it means for families, and what the foundation is working on. Free, and you can leave at any time.